Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Using ihMT MRI to assess myelin disruption in multiple sclerosis

Official title: Application of the Inhomogeneous Magnetisation Transfer MRI (ihMT) Technique, a New Myelin-specific MRI Technique, in Multiple Sclerosis

Run by Assistance Publique Hopitaux De Marseille · NCT03600779 · Data updated 2026-11-12

This study is trying out a new MRI technique to see if it can help track changes in myelin for people with early relapsing-remitting multiple sclerosis.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment85 (estimated)
SponsorAssistance Publique Hopitaux De Marseille
Academic / other
Locations1 site (Marseille, PACA)
StatusRecruiting
StartedJune 14, 2018
Main results expectedAugust 14, 2027
Study endsAugust 14, 2028
Registry record updatedAugust 6, 2026
Trial IDNCT03600779 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 to 45 with relapsing-remitting multiple sclerosis and active lesions on MRI.

Probably not a fit

Patients with progressive forms of MS or those with contraindications for MRI will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop in vivo biomarkers that can effectively monitor demyelination and remyelination processes in patients with multiple sclerosis (MS). The study utilizes a novel imaging technique called inhomogeneous Magnetisation Transfer (ihMT), which has shown promise in preliminary studies for its sensitivity in evaluating myelin disruption. By focusing on patients with early relapsing-remitting MS, the study seeks to measure and describe the spontaneous demyelination and remyelination processes involved in active lesions. Participants will undergo MRI scans to assess these processes over time.

Why it matters

Potential benefit: If successful, this study could provide a new method for monitoring the effectiveness of therapies aimed at repairing myelin in MS patients.

How similar studies have gone: Preliminary studies using similar ihMT techniques have shown promising results, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For Patients and Controls :

  * Adult patient, male and female, age 18 to 45
  * Patient affiliated with health insurance coverage,
  * Patient who signed a free and informed consent after receiving detailed, understandable and honest information,
* For patients only :

  * Patient with relapsing-remitting multiple sclerosis according to the McDonald 2010 criteria or progressive
  * Patients treated or not treated with first-line disease modifying therapy
  * Detection of at least one post-Gadolinium injection active lesion identified on the initial brain MRI (T0) or a chronic active lesion (PRL: Paramagnetic rim lesions)

Exclusion Criteria:

* For patients only :

  • Patients with a progressive form of MS other than the early relapsing-remitting form (primary progressive or secondary progressive)
* For Patients and Controls :

  * Patients with the usual contraindications for MRI (pacemaker, agitation, metal shards, claustrophobia)
  * Patients at risk of non-compliance to the exam: basic problems with understanding, confusion, involuntary movements, poor tolerance of prolonged supine position
  * Patients who are unable to give their consent: problems with understanding, lack of vigilance, confusion
  * Woman who is pregnant and breastfeeding
  * Patients with a history of neurological or psychiatric condition
  * Patients under guardianship or trusteeship

Where it's running

  • Assistance Publique Des Hotipaux de Marseille
    Marseille, Paca, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.